A gentleman in his late 60s, with a previous unilateral orchidectomy for suspected testicular cancer and 10 years of testosterone replacement therapy for hypogonadism, presented with an elevated prostate-specific antigen (PSA) level of 5.1 ng/mL. This evidence concerns the gene KLK3 and testicular cancer.